TY - JOUR
T1 - Gestational diabetes mellitus
T2 - results from a survey of country prevalence and practices
AU - Jiwani, Aliya
AU - Marseille, Elliot
AU - Lohse, Nicolai
AU - Damm, Peter
AU - Hod, Moshe
AU - Kahn, James G
PY - 2012/6
Y1 - 2012/6
N2 - Objective: The association between gestational diabetes mellitus (GDM), perinatal complications and long-term morbidity is gaining increased attention. However, the global burden of GDM and the existing responses are not fully understood. We aimed to assess country prevalence and to summarize practices related to GDM screening and management. Methods: Data on prevalence and country practices were obtained from a survey administered to diabetologists, obstetricians and others working on GDM in 173 countries. Results: GDM prevalence estimates range from 90%. Conclusions: We found large variations in estimated GDM prevalence, but direct comparison between countries is difficult due to different diagnostic strategies and subpopulations. Many countries do not perform systematic screening for GDM, and practices often diverge from guidelines. Countries need to carefully assess the cost and health impact of scaling up GDM screening and management in order to identify the best policy option for their population.
AB - Objective: The association between gestational diabetes mellitus (GDM), perinatal complications and long-term morbidity is gaining increased attention. However, the global burden of GDM and the existing responses are not fully understood. We aimed to assess country prevalence and to summarize practices related to GDM screening and management. Methods: Data on prevalence and country practices were obtained from a survey administered to diabetologists, obstetricians and others working on GDM in 173 countries. Results: GDM prevalence estimates range from 90%. Conclusions: We found large variations in estimated GDM prevalence, but direct comparison between countries is difficult due to different diagnostic strategies and subpopulations. Many countries do not perform systematic screening for GDM, and practices often diverge from guidelines. Countries need to carefully assess the cost and health impact of scaling up GDM screening and management in order to identify the best policy option for their population.
U2 - 10.3109/14767058.2011.587921
DO - 10.3109/14767058.2011.587921
M3 - Journal article
C2 - 21762003
SN - 1476-7058
VL - 25
SP - 600
EP - 610
JO - Journal of Maternal-Fetal Medicine
JF - Journal of Maternal-Fetal Medicine
IS - 6
ER -
